Glial fibrillary acidic protein in cerebrospinal fluid in humans is sensitive to various pre-analytical conditions: possible explanation and solution
Although glial fibrillary acidic protein (GFAP) has potential as a biomarker in cerebrospinal fluid, it is rarely used in clinical diagnosis due to high variability, low reliability, and poor reproducibility of results. Cerebrospinal fluid (CSF) was collected from patients (n = 167) at two sites at...
Saved in:
| Main Authors: | Björn Evertsson, Ingela Nilsson Remahl, Max Albert Hietala, Anja Finn |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Neurology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2025.1627405/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeting glial fibrillary acidic protein in glaucoma: a monoclonal antibody approach to modulate glial reactivity and neuroinflammation for neuroprotection
by: Chaoqiang Guan, et al.
Published: (2025-06-01) -
A single-center retrospective analysis of autoimmune glial fibrillary acidic protein astrocytopathy with seizures in children
by: Hongjun Fang, et al.
Published: (2025-06-01) -
A case of glial fibrillary acidotic protein (GFAP) meningoencephalitis with rheumatoid arthritis
by: Mehri Salari, et al.
Published: (2023-03-01) -
Current Trends in Stroke Biomarkers: The Prognostic Role of S100 Calcium-Binding Protein B and Glial Fibrillary Acidic Protein
by: Georgios Anogianakis, et al.
Published: (2024-10-01) -
Serum glial fibrillary protein reflects early brain injury dynamics and cognitive changes after deep brain stimulation surgery
by: Anika Frank, et al.
Published: (2025-05-01)